Clinical Trial Update: D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating D-cycloserine for chemotherapy-induced peripheral neuropathic pain in breast cancer patients was terminated, with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Northwestern University | Conditions: Neurotoxicity, Pain | Phase 3 | Status: TERMINATED | Results posted: 2013-12-02